One of the more interesting panels at last week's Health Datapalooza featured four speakers involved in the application of artificial intelligence to healthcare, including the creation of predictive models. In areas involving massive amounts of information in the diagnostic and genomic space, machine learning is already in use today, and the FDA is starting to approve applications of deep learning. For instance, a company called Arterys recently won FDA approval for its Cardio DL application, which uses deep learning to automate time-consuming analyses and tasks that are performed manually by clinicians today. Although they each come at it from a different angle based on their company's focus, there were several overarching themes the Datapalooza panelists tackled about the application of algorithms in healthcare, including the importance of transparency to getting clinician engagement. Getting buy-in from clinicians is a huge challenge, said Eric Just, a senior vice president for product development at Health Catalyst, which builds analytics and decision support tools for its health system customers.
The US Food and Drug Administration has announced that it is preparing to regulate AI systems that can update and improve themselves as they gorge on more training data. The announcement: The agency released a white paper proposing a regulatory framework to decide how medical products that use AI should seek approval before they can go on the market. It is the biggest step the FDA has taken to date toward formalizing oversight of products that use machine learning (ML). The challenge: Machine-learning systems are tricky to regulate because they can continuously update and improve their performance through new training data. In instances where the FDA has approved ML-based medical software before, it has required the algorithms to be "frozen" before commercial deployment and to go through a reapproval process when they are changed.
Artificial Intelligence already had a massive impact in the past years, but where will AI be in the coming years? Here is a list of predictions. Waiting to make their moveAsia's looming labour shortage p There is an obvious solution p print-edition iconFrom the print edition Asia p Feb 11th 2017 p THE … The first FDA approval for a machine learning application to be used in a clinical setting is a big step forward for AI and machine learning in healthcare and industry as a whole. Until recently, artificial intelligence (AI) was similar to nuclear fusion in unfulfilled promise. ManpowerGroup, one of the world's largest jobs companies, released a report detailing how the technological revolution is going to change the … Replacing the real world with a virtual one is a neat trick.
The 19th-century U.K. Locomotive Act, also known as the Red Flag Act, required motorized vehicles to be preceded by a person waving a red flag to signal the oncoming danger. Movies can be a good place to see what the future looks like. According to Robert Wallace, a retired director of the CIA's Office of Technical Service: "... When a new James Bond movie was released, we always got calls asking, 'Do you have one of those?' If I answered'no', the next question was, 'How long will it take you to make it?' Folks didn't care about the laws of physics or that Q was an actor in a fictional series--his character and inventiveness pushed our imagination ..."3 As an example, the CIA successfully copied the shoe-mounted spring-loaded and poison-tipped knife in From Russia With Love. It's interesting to speculate on what else Bond movies may have led to being invented. For this reason, I have been considering what movies predict about the future of artificial intelligence (AI).
The experimental Smart Tissue Autonomous Robot (STAR) recently sewed a piglet's gut together using a computer program and camera-based guidance, overseen by a team of doctors and computer scientists from the Children's National Health System in Washington DC and Johns Hopkins University. The procedure took 50 minutes, as opposed to 8 minutes when performed by a surgeon, but (unfortunately for doctors) resulted in more evenly spaced sutures and less leakage from the gut. And with iterative improvements, it's likely that the time difference can be shrunk. Meanwhile, FDA-approved robotic surgery on humans is making strides as well, though it requires a surgeon to operate the mechanical arm. The potential treatment paradigm, highlighted by The Economist this month, raises questions about whether patients will trust robots with their lives, and who is liable if something goes wrong.